Sympathische Ophthalmie: Therapie mit steroidsparendem Immunsuppressivum Azathioprin

K. Wand; M. Straub; C. P. Lohmann; C. S. Mayer

doi:10.1007/s00347-016-0227-7

Sympathische Ophthalmie: Therapie mit steroidsparendem Immunsuppressivum Azathioprin

Translated title of the contribution: Sympathetic ophthalmia: Therapy with steroid-free immunosuppressant azathioprine

K. Wand, M. Straub, C. P. Lohmann, C. S. Mayer

Department of Ophthalmology

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

Abstract

This article describes the case of a 48-year-old male patient who presented with persistent inflammation and deterioration of vision to a best corrected visual acuity (BCVA) of 0.6 in the only functioning left eye. The right eye had suffered a severe penetrating ocular trauma 6 months prior to presentation. After diagnosis of a sympathetic ophthalmia a high dosage corticosteroid therapy was initiated. Due to intolerance with decompensating diabetes an immunosuppressive therapy with azathioprine was initiated. This therapy resulted in stable clinical findings with an increase in BCVA to 0.9.

Translated title of the contribution	Sympathetic ophthalmia: Therapy with steroid-free immunosuppressant azathioprine
Original language	German
Pages (from-to)	867-869
Number of pages	3
Journal	Ophthalmologe
Volume	113
Issue number	10
DOIs	https://doi.org/10.1007/s00347-016-0227-7
State	Published - 1 Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00347-016-0227-7

Cite this

@article{b065eb2c58ec4440829ce8b099dc4644,

title = "Sympathische Ophthalmie: Therapie mit steroidsparendem Immunsuppressivum Azathioprin",

abstract = "This article describes the case of a 48-year-old male patient who presented with persistent inflammation and deterioration of vision to a best corrected visual acuity (BCVA) of 0.6 in the only functioning left eye. The right eye had suffered a severe penetrating ocular trauma 6 months prior to presentation. After diagnosis of a sympathetic ophthalmia a high dosage corticosteroid therapy was initiated. Due to intolerance with decompensating diabetes an immunosuppressive therapy with azathioprine was initiated. This therapy resulted in stable clinical findings with an increase in BCVA to 0.9.",

keywords = "Azathioprine, Cortisone, Granulomatous inflammation, Immunosuppression, Uveitis",

author = "K. Wand and M. Straub and Lohmann, {C. P.} and Mayer, {C. S.}",

note = "Publisher Copyright: {\textcopyright} 2016, Springer-Verlag Berlin Heidelberg.",

year = "2016",

month = oct,

day = "1",

doi = "10.1007/s00347-016-0227-7",

language = "Deutsch",

volume = "113",

pages = "867--869",

journal = "Ophthalmologe",

issn = "0941-293X",

publisher = "Springer Medizin",

number = "10",

}

TY - JOUR

T1 - Sympathische Ophthalmie

T2 - Therapie mit steroidsparendem Immunsuppressivum Azathioprin

AU - Wand, K.

AU - Straub, M.

AU - Lohmann, C. P.

AU - Mayer, C. S.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - This article describes the case of a 48-year-old male patient who presented with persistent inflammation and deterioration of vision to a best corrected visual acuity (BCVA) of 0.6 in the only functioning left eye. The right eye had suffered a severe penetrating ocular trauma 6 months prior to presentation. After diagnosis of a sympathetic ophthalmia a high dosage corticosteroid therapy was initiated. Due to intolerance with decompensating diabetes an immunosuppressive therapy with azathioprine was initiated. This therapy resulted in stable clinical findings with an increase in BCVA to 0.9.

AB - This article describes the case of a 48-year-old male patient who presented with persistent inflammation and deterioration of vision to a best corrected visual acuity (BCVA) of 0.6 in the only functioning left eye. The right eye had suffered a severe penetrating ocular trauma 6 months prior to presentation. After diagnosis of a sympathetic ophthalmia a high dosage corticosteroid therapy was initiated. Due to intolerance with decompensating diabetes an immunosuppressive therapy with azathioprine was initiated. This therapy resulted in stable clinical findings with an increase in BCVA to 0.9.

KW - Azathioprine

KW - Cortisone

KW - Granulomatous inflammation

KW - Immunosuppression

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=84958242721&partnerID=8YFLogxK

U2 - 10.1007/s00347-016-0227-7

DO - 10.1007/s00347-016-0227-7

M3 - Artikel

C2 - 26879557

AN - SCOPUS:84958242721

SN - 0941-293X

VL - 113

SP - 867

EP - 869

JO - Ophthalmologe

JF - Ophthalmologe

IS - 10

ER -

Sympathische Ophthalmie: Therapie mit steroidsparendem Immunsuppressivum Azathioprin

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this